Head scientist leaves CIRM

Arlene Chiu, the interim chief scientific officer at the linkurl:California Institute for Regenerative Medicine;http://www.the-scientist.com/article/display/22768/ , has announced that she will step down from her post at the end of October. In a CIRM statement Chiu writes that she'll be moving from San Francisco, where CIRM is headquartered to her home in Los Angeles to "pursue new professional directions." Chiu will serve as a consultant to the agency through April 2008, advising newly chosen

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Arlene Chiu, the interim chief scientific officer at the linkurl:California Institute for Regenerative Medicine;http://www.the-scientist.com/article/display/22768/ , has announced that she will step down from her post at the end of October. In a CIRM statement Chiu writes that she'll be moving from San Francisco, where CIRM is headquartered to her home in Los Angeles to "pursue new professional directions." Chiu will serve as a consultant to the agency through April 2008, advising newly chosen interim president linkurl:Richard Murphy;http://www.the-scientist.com/news/display/53480/ , recruiting individuals to CIRM's scientific team and helping craft CIRM's 2008 scientific agenda. Chiu's announcement comes amidst criticism from some that California's stem cell agency, which was tasked in 2004 with doling out $3 billion in state funds to support stem cell research, is dragging its feet in finding a permanent president since linkurl:Zach Hall;http://www.emory.edu/PROVOST/SamNunnForum/speakers/hall.html , CIRM's last permanent president, announced his retirement last December and left the institute in April. "I believe Dr. Chiu's departure underscores the importance of the oversight committee performing its single most important task: hiring a president and chief executive," writes John Simpson, with the Foundation for Taxpayer and Consumer Rights--a watchdog group that keeps tabs on CIRM--in a statement. "Had the committee done so in a timely way, I believe Dr. Chiu would still be at CIRM." Chiu joined CIRM in 2005 as the agency's director of scientific activities. She helped assemble CIRM's scientific team, which linkurl:awarded;http://www.the-scientist.com/blog/display/52856/ the first $200 million in California state funds to stem cell researchers. Before that, Chiu was the associate director of the Office of Research Administration for the National Institute of Biomedical Imaging and Bioengineering at NIH. "Arlene has left her mark on the DNA of CIRM," writes Hall in another statement, "She will be hard to replace." Hall acted as both president and CSO during his tenure at CIRM, and Chiu took over as interim CSO when Hall left. CIRM spokesperson Dale Carlson says that who is named as CIRM's next chief scientific officer will depend on who the agency selects as the next permanent president. Stay tuned to **__The Scientist__** as we follow the situation at CIRM and discover who will fill Chiu's shoes.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control